“Review 2021 Year-end Special Notes” series 4: Highlights of work of drug and Medical Device Circulation Supervision Office in 2021

2022-08-06 0 By

In 2021, the beginning year of the “14th Five-year Plan”, the PEOPLE’s Drug Administration’s original heart is like rock.In 2021, Anhui Provincial Food and Drug Administration will make full efforts and blossom in more places.We insist on people first, strengthen the system thinking, shift work idea, pay attention to the reform of open innovation, as a whole “adherence to drug safety bottom line” and “promote the development of medicine industry, high quality”, promoting “for the drug safety promotion action”, “safe” and “promoting development” with power, double break, a total of ascension, to ensure the safety of the provincial drug situation continued stability of positive,The overall quality and safety of novel Coronavirus vaccines in Anhui province remains stable. Strong progress has been made in improving the capacity for drug supervision, and the high-quality development of the pharmaceutical industry has produced numerous highlights and outstanding results.The New Year begins a new journey.Anhui pharmaceutical regulatory force planning “review 2021 year-end special notes” series of reports.Looking back on 2021, we will review our hard work together.Looking forward to 2022, we will work together to promote the new development of the drug administration.One hundred years of struggle on the grand answer.Today, we bring you the fourth report in our series.Disclaimer: This article is reproduced for the purpose of conveying more information.If the source is wrong or violated your legitimate rights and interests, please contact the author with proof of ownership, we will promptly correct, delete, thank you.Email address: newmedia@xxcb.cn